D
Dana P. Goldman
Researcher at University of Southern California
Publications - 381
Citations - 16877
Dana P. Goldman is an academic researcher from University of Southern California. The author has contributed to research in topics: Health care & Population. The author has an hindex of 62, co-authored 377 publications receiving 15247 citations. Previous affiliations of Dana P. Goldman include George Washington University & Dana Corporation.
Papers
More filters
Journal ArticleDOI
Patients Value Metastatic Cancer Therapy More Highly Than Is Typically Shown Through Traditional Estimates
TL;DR: It is found that patients place high valuations on metastatic cancer therapy--on average, twenty-three times higher than its cost--and that other traditional methods used to estimate the value of these treatments for patients significantly undervalues how patients view them.
Journal Article
Physician prescribing behavior and its impact on patient-level outcomes.
TL;DR: How broadly physicians prescribe within the 10 most prevalent therapeutic classes, the factors affecting their choices, and the impact of their prescribing behavior on patient-level outcomes are examined.
Posted Content
Food Prices and the Dynamics of Body Weight
TL;DR: In this article, the authors studied the short-term and long-term effects of price per calorie on body weight in the Health and Retirement Study (HRS) and found that, within 30 years, a 10% permanent reduction in price per calories would lead to a BMI increase of 1.5 units (or 3.6%).
Journal Article
Bending the curve: effective steps to address long-term healthcare spending growth.
Joseph Antos,John Bertko,Michael E. Chernew,David M. Cutler,Dana P. Goldman,Dana P. Goldman,Mark McClellan,Elizabeth A. McGlynn,Mark V. Pauly,Leonard D. Schaeffer,Stephen M. Shortell +10 more
TL;DR: Findings show that inefficiencies in the current system both increase costs and reduce quality, and identifying a set of reforms that can credibly and practically achieve this goal has been difficult.
Journal ArticleDOI
Measuring the Incremental Cost of Clinical Cancer Research
Dana P. Goldman,Michael Schoenbaum,Arnold L. Potosky,Jane C. Weeks,Sandra H. Berry,José J. Escarce,Beverly A. Weidmer,Meredith L. Kilgore,Nikhil Wagle,John L. Adams,Robert A. Figlin,Joy H Lewis,Joel Cohen,Richard Kaplan,Mary S. McCabe +14 more
TL;DR: The results should be of great interest to insurers and the research community as they consider permanent ways to finance cancer trials and changes to these policies would not be expensive, but these results are not generalizable.